Agricultural Biotechnology for Transgenic Crops Market by Trait Type (Drought Tolerance, Herbicide Tolerance, Insect Resistance), Crop Type (Canola, Cotton, Maize), Application, End User - Global Forecast 2025-2032
Description
The Agricultural Biotechnology for Transgenic Crops Market was valued at USD 1.21 billion in 2024 and is projected to grow to USD 1.31 billion in 2025, with a CAGR of 8.82%, reaching USD 2.38 billion by 2032.
A concise strategic framing of how genetic trait innovation, regulatory dynamics, and supply-chain realities converge to reshape transgenic crop deployment and decision making
The evolution of agricultural biotechnology has accelerated the development and deployment of transgenic crops that address biotic and abiotic stressors, improve input efficiency, and enable novel value chains. This report synthesizes cross-disciplinary evidence from regulatory updates, trait innovation, crop adoption patterns, and end-user demands to present an integrated executive assessment. Readers will find contextualized analysis designed to support commercial strategy, policy planning, and research prioritization without recourse to speculative financial projections.
Throughout the report, we draw on peer-reviewed research, regulatory filings, and primary interviews to illustrate how genetic modification tools and trait stewardship are reshaping cropping systems. We also examine how commercialization pathways intersect with supply chains, seed distribution networks, and extension services. In doing so, the analysis highlights where scientific breakthroughs can translate into field-level benefits and where institutional friction may slow translation.
Finally, the introduction frames key themes that recur in later sections: the interplay between technology and regulation, the strategic implications of tariff policy, and the segmentation and regional dynamics that determine who benefits from transgenic innovation. With this framing in place, readers can move into deeper sections that unpack transformative shifts, tariff impacts, segmentation insights, regional differentiation, and strategic recommendations grounded in observed industry actions.
Emerging technical, regulatory, and partnership dynamics that are collectively transforming how transgenic traits are developed, commercialized, and integrated within agricultural value chains
The landscape for transgenic crops is experiencing several transformative shifts that extend beyond laboratory breakthroughs to affect commercialization, stewardship, and market access. Advances in gene editing and trait stacking are enabling more precise trait combinations that address drought tolerance, herbicide tolerance, and insect resistance within single cultivars. Alongside technical progress, regulatory pathways in multiple jurisdictions have evolved to accommodate new breeding technologies, changing the timeline and cost structure for bringing modified crops to market.
Concurrently, private-public partnerships and collaborative breeding consortia are becoming more common, enabling technology transfer and localized trait adaptation. This cooperative approach accelerates varietal testing and can lower entry barriers for seed companies and research institutions. Meanwhile, farmers and end-users increasingly demand traits that deliver measurable on-farm resilience and quality improvements, pushing developers to prioritize traits with demonstrable agronomic and processing benefits.
Supply-chain actors are also adapting: processors and feed manufacturers are refining segregation and traceability systems to manage coexistence requirements, and risk management practices such as stewardship agreements and monitoring protocols are expanding. Taken together, these shifts create a dynamic environment in which technological potential must be matched by pragmatic commercialization strategies that account for regulatory landscapes, partnership models, and evolving end-user expectations.
How recent US tariff policy changes have reshaped sourcing, trade routing, and risk management strategies across seed, input, and processing value chains in agricultural biotechnology
The United States tariff framework introduced in 2025 has added a new dimension to the operational environment for agricultural biotechnology, affecting international trade flows, input sourcing, and cost structures across the value chain. These tariff adjustments have influenced decisions by seed companies and processors to re-evaluate sourcing strategies for germplasm, technologies, and bioproduct components. As a result, firms have been reassessing supplier relationships and logistical arrangements to preserve competitiveness while maintaining compliance with trade rules.
Beyond procurement, the tariff environment has prompted refinements in market access strategies. Exporters and international distributors have explored alternative routing and value-added services to mitigate customs friction, while some firms have increased focus on regional production hubs to shorten supply chains and reduce exposure to cross-border tariff risk. Regulatory compliance teams have also deepened their scrutiny of origin documentation and certification processes to ensure tariff classifications align with product attributes and legal obligations.
Importantly, stakeholders have responded by enhancing scenario planning and stress-testing commercial models against trade-policy shifts. This has led to investment in trade analytics, closer collaboration with customs experts, and more robust contractual terms that allocate tariff-related risks between buyers and sellers. These measures reflect a pragmatic adaptation to a policy environment that can alter incentives for cross-border movement of transgenic seeds, trait licenses, and related inputs.
A nuanced segmentation-driven perspective that links trait priorities, crop-specific development pathways, application requirements, and diverse end-user needs to strategic decision making
Segmentation analysis reveals where development priorities and commercialization strategies diverge according to the trait targets under development and the crops in which they are deployed. When examined by trait type, investments and field trials concentrate on drought tolerance, herbicide tolerance, and insect resistance, each of which drives distinct breeding priorities and stewardship requirements. Drought tolerance demands partnerships with agronomy teams to validate performance across diverse moisture regimes; herbicide tolerance requires coordinated stewardship and compatibility testing with chemical portfolios; insect resistance hinges on refuge design and resistance-monitoring protocols.
Looking across crop types, the landscape differs substantially between canola, cotton, maize, and soybean, with each crop presenting unique agronomic cycles, seed system dynamics, and downstream processing requirements. For example, trait stacking strategies in maize emphasize hybrid vigor and yield consistency, while cotton programs must balance fiber quality with pest management. Soybean programs often consider oil and protein processing implications, and canola development integrates both agronomic and processing quality targets.
Application-based segmentation further clarifies commercialization pathways, with biofuel, food and feed, pharmaceutical, and processing end-uses shaping trait priorities and regulatory considerations. Each application imposes different traceability, purity, and quality constraints that developers must address. Finally, parsing the market by end-user reveals varied needs among biotech companies, farmers, government bodies, research institutions, and seed companies. This perspective highlights where partnership models, extension services, and policy engagement can most effectively accelerate adoption and manage risk.
How regional regulatory stances, seed-system maturity, and supply-chain infrastructure across the Americas, Europe, Middle East & Africa, and Asia-Pacific shape transgenic crop strategies
Regional dynamics exert a strong influence on regulatory approaches, trait adoption, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established seed systems and large-scale commercial agriculture support rapid field-trial throughput and enable early adoption of stacked traits, yet regional regulatory nuances and export orientation continue to shape commercialization timelines. This creates an environment where private-sector investment in breeding and stewardship often aligns with large-scale farming operations.
In Europe, Middle East & Africa, regulatory frameworks and public sentiment tend to impose higher scrutiny on transgenic technologies, requiring developers to invest in extensive risk communication and localized performance validation. This region’s heterogeneity in agroecological zones and policy stances encourages flexible commercialization models, including localized breeding programs and public-private trials. In contrast, the Asia-Pacific region presents a mix of high-adoption markets with advanced seed systems alongside emerging markets with growing research capacity; developers must therefore tailor market entry strategies to account for diverse regulatory regimes, seed distribution channels, and end-user expectations.
Across regions, supply-chain considerations such as segregation, traceability, and processing infrastructure determine where certain traits create the greatest near-term value. Consequently, regional strategies increasingly combine technological development with investments in local capacity building, regulatory engagement, and extension programs to translate trait innovation into durable on-farm and processing outcomes.
Observed corporate strategies and collaborative models that drive competitive differentiation through integrated trait development, stewardship, and market access capabilities
Key company behaviors illuminate strategic priorities and competitive dynamics within agricultural biotechnology. Leading developers are focusing on deepening trait portfolios through stacking and modular trait platforms that allow rapid combination of drought tolerance, herbicide tolerance, and insect resistance characteristics tailored to crop-specific needs. These firms tend to invest in expansive breeding pipelines, field-trial networks, and regulatory affairs teams to support multi-jurisdictional submissions and stewardship commitments.
Seed companies and specialty biotech firms are increasingly forming alliances with processors and distribution partners to secure downstream demand and to manage segregation and traceability obligations. Research institutions and public breeding programs contribute by adapting traits to local germplasm, conducting independent agronomic validations, and training extension networks. Government bodies play a complementary role through regulatory guidance, funding for public-good traits, and frameworks that encourage technology transfer.
Across this ecosystem, players differentiate themselves through service offerings such as stewardship programs, digital agronomy tools, and licensing models that balance commercial returns with adoption incentives. Observed behavior indicates that competitive advantage increasingly accrues to organizations that can integrate trait development with pragmatic commercialization infrastructure, regulatory foresight, and credible on-farm performance data.
Practical strategic actions for industry leaders to align R&D, partnerships, regulatory readiness, and stewardship to accelerate commercial adoption and risk mitigation
Industry leaders can take immediate steps to strengthen commercialization outcomes and reduce regulatory and trade friction. First, align R&D priorities with downstream processing and end-user requirements to ensure traits deliver measurable agronomic or product-quality benefits. This alignment should be supported by rigorous on-farm validation programs and stakeholder-facing evidence packages that demonstrate value under real-world conditions.
Second, construct flexible partnership frameworks that combine the strengths of biotech developers, seed companies, research institutions, and government entities. Such partnerships can accelerate varietal adaptation, expand trial networks, and distribute commercialization risk. Third, invest in trade and regulatory intelligence capabilities to preempt classification disputes and tariff impacts, while also strengthening origin documentation and contractual clauses that allocate policy risk between parties.
Fourth, scale up stewardship, traceability, and segregation systems proportionate to the crops and applications targeted, integrating digital tools where feasible to reduce compliance costs and improve transparency. Finally, prioritize capacity building and localized engagement in target regions to ensure that adoption pathways reflect local agronomic realities and stakeholder expectations, thereby increasing the likelihood of sustainable, long-term uptake.
An evidence-driven methodological approach combining primary stakeholder interviews, regulatory and technical literature synthesis, and triangulated case-study analysis to ensure robust findings
The research methodology underpinning this analysis integrates qualitative and quantitative evidence streams to create a comprehensive view of the transgenic crop landscape. Primary research included structured interviews with developers, seed system stakeholders, regulatory specialists, and supply-chain participants to capture real-time strategic responses to technological and policy changes. Secondary sources comprised peer-reviewed literature, regulatory filings, and public domain technical documents that inform discussions of trait performance, stewardship practices, and regulatory evolution.
Triangulation techniques were applied to validate key findings across data sources and to reconcile divergent perspectives. The methodology emphasizes transparency regarding data provenance and analytical assumptions while avoiding speculative projections. Where appropriate, case studies illustrate how specific trait deployments, crop programs, or trade-policy responses played out in real operational contexts, enabling practical lessons for stakeholders.
Finally, sensitivity checks and scenario analyses were used to stress-test strategic implications against alternative regulatory and trade-policy pathways. This approach ensures that recommendations are robust across plausible operational conditions and grounded in observable behavior rather than hypothetical market forecasts.
Concluding synthesis that emphasizes pragmatic integration of technology, regulatory foresight, and operational readiness to convert transgenic innovation into durable agricultural value
The conclusion synthesizes core insights and reiterates the practical implications for decision-makers navigating transgenic crop development and commercialization. Technological progress in trait engineering offers clear pathways to improve resilience, input efficiency, and product quality, but realizing these benefits depends on coordinated execution across breeding, regulation, supply chains, and end-user engagement. Stakeholders that integrate technical excellence with regulatory foresight and operational preparedness will be best positioned to capture durable benefits.
In addition, the policy environment, including tariff measures and evolving regulatory stances, requires adaptive strategies that combine scenario planning, contractual risk allocation, and investments in trade compliance. Regional differences underscore the need for tailored commercialization approaches that reflect local seed systems, processing capacity, and stakeholder expectations. Ultimately, companies and institutions that invest in partnerships, stewardship systems, and transparent evidence-generation will accelerate adoption while managing reputational and regulatory risk.
Taken together, these insights point to a pragmatic pathway: prioritize traits with demonstrable on-farm value, build flexible collaborations to accelerate deployment, and institutionalize regulatory and trade-risk management practices to sustain long-term market access and stakeholder trust.
Please Note: PDF & Excel + Online Access - 1 Year
A concise strategic framing of how genetic trait innovation, regulatory dynamics, and supply-chain realities converge to reshape transgenic crop deployment and decision making
The evolution of agricultural biotechnology has accelerated the development and deployment of transgenic crops that address biotic and abiotic stressors, improve input efficiency, and enable novel value chains. This report synthesizes cross-disciplinary evidence from regulatory updates, trait innovation, crop adoption patterns, and end-user demands to present an integrated executive assessment. Readers will find contextualized analysis designed to support commercial strategy, policy planning, and research prioritization without recourse to speculative financial projections.
Throughout the report, we draw on peer-reviewed research, regulatory filings, and primary interviews to illustrate how genetic modification tools and trait stewardship are reshaping cropping systems. We also examine how commercialization pathways intersect with supply chains, seed distribution networks, and extension services. In doing so, the analysis highlights where scientific breakthroughs can translate into field-level benefits and where institutional friction may slow translation.
Finally, the introduction frames key themes that recur in later sections: the interplay between technology and regulation, the strategic implications of tariff policy, and the segmentation and regional dynamics that determine who benefits from transgenic innovation. With this framing in place, readers can move into deeper sections that unpack transformative shifts, tariff impacts, segmentation insights, regional differentiation, and strategic recommendations grounded in observed industry actions.
Emerging technical, regulatory, and partnership dynamics that are collectively transforming how transgenic traits are developed, commercialized, and integrated within agricultural value chains
The landscape for transgenic crops is experiencing several transformative shifts that extend beyond laboratory breakthroughs to affect commercialization, stewardship, and market access. Advances in gene editing and trait stacking are enabling more precise trait combinations that address drought tolerance, herbicide tolerance, and insect resistance within single cultivars. Alongside technical progress, regulatory pathways in multiple jurisdictions have evolved to accommodate new breeding technologies, changing the timeline and cost structure for bringing modified crops to market.
Concurrently, private-public partnerships and collaborative breeding consortia are becoming more common, enabling technology transfer and localized trait adaptation. This cooperative approach accelerates varietal testing and can lower entry barriers for seed companies and research institutions. Meanwhile, farmers and end-users increasingly demand traits that deliver measurable on-farm resilience and quality improvements, pushing developers to prioritize traits with demonstrable agronomic and processing benefits.
Supply-chain actors are also adapting: processors and feed manufacturers are refining segregation and traceability systems to manage coexistence requirements, and risk management practices such as stewardship agreements and monitoring protocols are expanding. Taken together, these shifts create a dynamic environment in which technological potential must be matched by pragmatic commercialization strategies that account for regulatory landscapes, partnership models, and evolving end-user expectations.
How recent US tariff policy changes have reshaped sourcing, trade routing, and risk management strategies across seed, input, and processing value chains in agricultural biotechnology
The United States tariff framework introduced in 2025 has added a new dimension to the operational environment for agricultural biotechnology, affecting international trade flows, input sourcing, and cost structures across the value chain. These tariff adjustments have influenced decisions by seed companies and processors to re-evaluate sourcing strategies for germplasm, technologies, and bioproduct components. As a result, firms have been reassessing supplier relationships and logistical arrangements to preserve competitiveness while maintaining compliance with trade rules.
Beyond procurement, the tariff environment has prompted refinements in market access strategies. Exporters and international distributors have explored alternative routing and value-added services to mitigate customs friction, while some firms have increased focus on regional production hubs to shorten supply chains and reduce exposure to cross-border tariff risk. Regulatory compliance teams have also deepened their scrutiny of origin documentation and certification processes to ensure tariff classifications align with product attributes and legal obligations.
Importantly, stakeholders have responded by enhancing scenario planning and stress-testing commercial models against trade-policy shifts. This has led to investment in trade analytics, closer collaboration with customs experts, and more robust contractual terms that allocate tariff-related risks between buyers and sellers. These measures reflect a pragmatic adaptation to a policy environment that can alter incentives for cross-border movement of transgenic seeds, trait licenses, and related inputs.
A nuanced segmentation-driven perspective that links trait priorities, crop-specific development pathways, application requirements, and diverse end-user needs to strategic decision making
Segmentation analysis reveals where development priorities and commercialization strategies diverge according to the trait targets under development and the crops in which they are deployed. When examined by trait type, investments and field trials concentrate on drought tolerance, herbicide tolerance, and insect resistance, each of which drives distinct breeding priorities and stewardship requirements. Drought tolerance demands partnerships with agronomy teams to validate performance across diverse moisture regimes; herbicide tolerance requires coordinated stewardship and compatibility testing with chemical portfolios; insect resistance hinges on refuge design and resistance-monitoring protocols.
Looking across crop types, the landscape differs substantially between canola, cotton, maize, and soybean, with each crop presenting unique agronomic cycles, seed system dynamics, and downstream processing requirements. For example, trait stacking strategies in maize emphasize hybrid vigor and yield consistency, while cotton programs must balance fiber quality with pest management. Soybean programs often consider oil and protein processing implications, and canola development integrates both agronomic and processing quality targets.
Application-based segmentation further clarifies commercialization pathways, with biofuel, food and feed, pharmaceutical, and processing end-uses shaping trait priorities and regulatory considerations. Each application imposes different traceability, purity, and quality constraints that developers must address. Finally, parsing the market by end-user reveals varied needs among biotech companies, farmers, government bodies, research institutions, and seed companies. This perspective highlights where partnership models, extension services, and policy engagement can most effectively accelerate adoption and manage risk.
How regional regulatory stances, seed-system maturity, and supply-chain infrastructure across the Americas, Europe, Middle East & Africa, and Asia-Pacific shape transgenic crop strategies
Regional dynamics exert a strong influence on regulatory approaches, trait adoption, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established seed systems and large-scale commercial agriculture support rapid field-trial throughput and enable early adoption of stacked traits, yet regional regulatory nuances and export orientation continue to shape commercialization timelines. This creates an environment where private-sector investment in breeding and stewardship often aligns with large-scale farming operations.
In Europe, Middle East & Africa, regulatory frameworks and public sentiment tend to impose higher scrutiny on transgenic technologies, requiring developers to invest in extensive risk communication and localized performance validation. This region’s heterogeneity in agroecological zones and policy stances encourages flexible commercialization models, including localized breeding programs and public-private trials. In contrast, the Asia-Pacific region presents a mix of high-adoption markets with advanced seed systems alongside emerging markets with growing research capacity; developers must therefore tailor market entry strategies to account for diverse regulatory regimes, seed distribution channels, and end-user expectations.
Across regions, supply-chain considerations such as segregation, traceability, and processing infrastructure determine where certain traits create the greatest near-term value. Consequently, regional strategies increasingly combine technological development with investments in local capacity building, regulatory engagement, and extension programs to translate trait innovation into durable on-farm and processing outcomes.
Observed corporate strategies and collaborative models that drive competitive differentiation through integrated trait development, stewardship, and market access capabilities
Key company behaviors illuminate strategic priorities and competitive dynamics within agricultural biotechnology. Leading developers are focusing on deepening trait portfolios through stacking and modular trait platforms that allow rapid combination of drought tolerance, herbicide tolerance, and insect resistance characteristics tailored to crop-specific needs. These firms tend to invest in expansive breeding pipelines, field-trial networks, and regulatory affairs teams to support multi-jurisdictional submissions and stewardship commitments.
Seed companies and specialty biotech firms are increasingly forming alliances with processors and distribution partners to secure downstream demand and to manage segregation and traceability obligations. Research institutions and public breeding programs contribute by adapting traits to local germplasm, conducting independent agronomic validations, and training extension networks. Government bodies play a complementary role through regulatory guidance, funding for public-good traits, and frameworks that encourage technology transfer.
Across this ecosystem, players differentiate themselves through service offerings such as stewardship programs, digital agronomy tools, and licensing models that balance commercial returns with adoption incentives. Observed behavior indicates that competitive advantage increasingly accrues to organizations that can integrate trait development with pragmatic commercialization infrastructure, regulatory foresight, and credible on-farm performance data.
Practical strategic actions for industry leaders to align R&D, partnerships, regulatory readiness, and stewardship to accelerate commercial adoption and risk mitigation
Industry leaders can take immediate steps to strengthen commercialization outcomes and reduce regulatory and trade friction. First, align R&D priorities with downstream processing and end-user requirements to ensure traits deliver measurable agronomic or product-quality benefits. This alignment should be supported by rigorous on-farm validation programs and stakeholder-facing evidence packages that demonstrate value under real-world conditions.
Second, construct flexible partnership frameworks that combine the strengths of biotech developers, seed companies, research institutions, and government entities. Such partnerships can accelerate varietal adaptation, expand trial networks, and distribute commercialization risk. Third, invest in trade and regulatory intelligence capabilities to preempt classification disputes and tariff impacts, while also strengthening origin documentation and contractual clauses that allocate policy risk between parties.
Fourth, scale up stewardship, traceability, and segregation systems proportionate to the crops and applications targeted, integrating digital tools where feasible to reduce compliance costs and improve transparency. Finally, prioritize capacity building and localized engagement in target regions to ensure that adoption pathways reflect local agronomic realities and stakeholder expectations, thereby increasing the likelihood of sustainable, long-term uptake.
An evidence-driven methodological approach combining primary stakeholder interviews, regulatory and technical literature synthesis, and triangulated case-study analysis to ensure robust findings
The research methodology underpinning this analysis integrates qualitative and quantitative evidence streams to create a comprehensive view of the transgenic crop landscape. Primary research included structured interviews with developers, seed system stakeholders, regulatory specialists, and supply-chain participants to capture real-time strategic responses to technological and policy changes. Secondary sources comprised peer-reviewed literature, regulatory filings, and public domain technical documents that inform discussions of trait performance, stewardship practices, and regulatory evolution.
Triangulation techniques were applied to validate key findings across data sources and to reconcile divergent perspectives. The methodology emphasizes transparency regarding data provenance and analytical assumptions while avoiding speculative projections. Where appropriate, case studies illustrate how specific trait deployments, crop programs, or trade-policy responses played out in real operational contexts, enabling practical lessons for stakeholders.
Finally, sensitivity checks and scenario analyses were used to stress-test strategic implications against alternative regulatory and trade-policy pathways. This approach ensures that recommendations are robust across plausible operational conditions and grounded in observable behavior rather than hypothetical market forecasts.
Concluding synthesis that emphasizes pragmatic integration of technology, regulatory foresight, and operational readiness to convert transgenic innovation into durable agricultural value
The conclusion synthesizes core insights and reiterates the practical implications for decision-makers navigating transgenic crop development and commercialization. Technological progress in trait engineering offers clear pathways to improve resilience, input efficiency, and product quality, but realizing these benefits depends on coordinated execution across breeding, regulation, supply chains, and end-user engagement. Stakeholders that integrate technical excellence with regulatory foresight and operational preparedness will be best positioned to capture durable benefits.
In addition, the policy environment, including tariff measures and evolving regulatory stances, requires adaptive strategies that combine scenario planning, contractual risk allocation, and investments in trade compliance. Regional differences underscore the need for tailored commercialization approaches that reflect local seed systems, processing capacity, and stakeholder expectations. Ultimately, companies and institutions that invest in partnerships, stewardship systems, and transparent evidence-generation will accelerate adoption while managing reputational and regulatory risk.
Taken together, these insights point to a pragmatic pathway: prioritize traits with demonstrable on-farm value, build flexible collaborations to accelerate deployment, and institutionalize regulatory and trade-risk management practices to sustain long-term market access and stakeholder trust.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of RNA interference techniques for targeted insect pest suppression in cotton
- 5.2. Adoption of herbicide tolerant soybean lines with stacked tolerance traits for weed management
- 5.3. Commercialization of biofortified rice varieties enriched with provitamin A to address malnutrition
- 5.4. Application of gene drive systems to control invasive pest populations in staple crops
- 5.5. Deployment of glyphosate and glufosinate dual-tolerant canola lines to improve yield stability
- 5.6. Implementation of next generation sequencing for regulatory approval of novel transgenic crops
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Agricultural Biotechnology for Transgenic Crops Market, by Trait Type
- 8.1. Drought Tolerance
- 8.2. Herbicide Tolerance
- 8.3. Insect Resistance
- 9. Agricultural Biotechnology for Transgenic Crops Market, by Crop Type
- 9.1. Canola
- 9.2. Cotton
- 9.3. Maize
- 9.4. Soybean
- 10. Agricultural Biotechnology for Transgenic Crops Market, by Application
- 10.1. Biofuel
- 10.2. Food & Feed
- 10.3. Pharmaceutical
- 10.4. Processing
- 11. Agricultural Biotechnology for Transgenic Crops Market, by End User
- 11.1. Biotech Companies
- 11.2. Farmers
- 11.3. Government Bodies
- 11.4. Research Institutions
- 11.5. Seed Companies
- 12. Agricultural Biotechnology for Transgenic Crops Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Agricultural Biotechnology for Transgenic Crops Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Agricultural Biotechnology for Transgenic Crops Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Arcadia Biosciences, Inc.
- 15.3.2. BASF SE
- 15.3.3. Bayer AG
- 15.3.4. Bioceres Crop Solutions Corp
- 15.3.5. Calyxt Inc.
- 15.3.6. Corteva, Inc.
- 15.3.7. Evogene Ltd
- 15.3.8. Groupe Limagrain
- 15.3.9. J.R. Simplot Co.
- 15.3.10. JK Agri Genetics Ltd.
- 15.3.11. KWS SAAT SE & Co. KGaA
- 15.3.12. Land O'Lakes, Inc.
- 15.3.13. Maharashtra Hybrid Seed Company
- 15.3.14. Nuseed Pty Ltd
- 15.3.15. Sakata Seed Corporation
- 15.3.16. Syngenta AG
- 15.3.17. UPL Limited
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
